Ajooni Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 102.91 million compared to INR 183.92 million a year ago. Revenue was INR 102.95 million compared to INR 184 million a year ago. Net income was INR 1.55 million compared to INR 3.53 million a year ago. Basic earnings per share from continuing operations was INR 0.032 compared to INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.032 compared to INR 0.07 a year ago.
For the six months, sales was INR 226.02 million compared to INR 342.38 million a year ago. Revenue was INR 226.13 million compared to INR 342.55 million a year ago. Net income was INR 4.77 million compared to INR 6.66 million a year ago. Basic earnings per share from continuing operations was INR 0.096 compared to INR 0.134 a year ago. Diluted earnings per share from continuing operations was INR 0.064 compared to INR 0.134 a year ago.